Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Andrašina

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Ceskoslovenska Patologie|June 22, 2012
Recurring multifocal leiomyosarcoma of the urinary bladder 22 years after therapy for bilateral (hereditary) retinoblastoma: a case report and review of the literatureM Svajdler, I Andrašina, D Ilenčíková, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|April 28, 2021
Occurrence of two histopathologically different malignanciesJ Tokarčík, D Slížová, I Andrašina, et al.
Physiological Research|March 3, 2020
Differential Urinary Proteomic Analysis of Endometrial CancerM Kacírová, P Bober, M Alexovič, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2025
Prolgolimab with chemotherapy as first-line treatment for advanced non-squamous non-small-cell lung cancerK Laktionov, A Smolin, D Stroyakovskiy, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Ceskoslovenska Patologie|June 22, 2012
Recurring multifocal leiomyosarcoma of the urinary bladder 22 years after therapy for bilateral (hereditary) retinoblastoma: a case report and review of the literatureM Svajdler, I Andrašina, D Ilenčíková, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|April 28, 2021
Occurrence of two histopathologically different malignanciesJ Tokarčík, D Slížová, I Andrašina, et al.
Physiological Research|March 3, 2020
Differential Urinary Proteomic Analysis of Endometrial CancerM Kacírová, P Bober, M Alexovič, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2025
Prolgolimab with chemotherapy as first-line treatment for advanced non-squamous non-small-cell lung cancerK Laktionov, A Smolin, D Stroyakovskiy, et al.
Pageof 1